INO Inovio Pharmaceuticals Inc

Price (delayed)

$1.18

Market cap

$122.01M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.91

Enterprise value

$98.48M

?
Relative Growth: Rel. Growth: 22
Relative Strength: Rel. Strength: 11
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 6

The complaint alleges that Inovio and certain officers made materially false and misleading statements regarding medical device manufacturing and FDA regulatory pathway eligibility during the Class Period of October 10, ...

Highlights
INO's EPS has surged by 65% year-on-year and by 37% since the previous quarter
Inovio Pharmaceuticals's debt has decreased by 25% YoY and by 8% QoQ
INO's revenue has dropped by 100% year-on-year
The gross profit has dropped by 100% year-on-year

Key stats

What are the main financial stats of INO

INO stock price

How has the Inovio Pharmaceuticals stock price performed over time
Intraday
-2.48%
1 week
8.26%
1 month
7.27%
1 year
-38.22%
YTD
-32.18%
QTD
7.27%

Financial performance

How have Inovio Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$79.26M
Net income
-$67.43M
Gross margin
N/A
Net margin
N/A
INO's revenue has dropped by 100% year-on-year
The gross profit has dropped by 100% year-on-year
INO's net income is up by 23% year-on-year and by 21% since the previous quarter
INO's operating income is up by 17% YoY and by 5% QoQ

Price vs fundamentals

How does INO's price correlate with its fundamentals

Growth

What is Inovio Pharmaceuticals's growth rate over time

Valuation

What is Inovio Pharmaceuticals stock price valuation
P/E
N/A
P/B
22.21
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
INO's EPS has surged by 65% year-on-year and by 37% since the previous quarter
The equity has plunged by 85% YoY and by 28% from the previous quarter
INO's revenue has dropped by 100% year-on-year

Efficiency

How efficient is Inovio Pharmaceuticals business performance
INO's ROE has plunged by 51% from the previous quarter
INO's return on assets is down by 19% year-on-year but it is up by 14% since the previous quarter

Dividends

What is INO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INO.

Financial health

How did Inovio Pharmaceuticals financials performed over time
The total assets is 10% greater than the total liabilities
INO's quick ratio is down by 40% year-on-year and by 7% since the previous quarter
INO's current ratio is down by 40% YoY and by 3.8% QoQ
Inovio Pharmaceuticals's debt is 83% higher than its equity
The equity has plunged by 85% YoY and by 28% from the previous quarter
The debt to equity has grown by 28% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.